Rosmantuzumab

Rosmantuzumab (OMP-131R10) is an anti-R-spondin 3 (RSPO3) humanized monoclonal antibody. Rosmantuzumab can be used for the research of advanced telapsed and refractory solid tumors[1].

Product Specifications

CAS Number

[1684393-04-1]

Product Name Alternative

OMP-131R10

UNSPSC

12352203

Target

Wnt

Type

Inhibitory Antibodies

Related Pathways

Stem Cell/Wnt

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/rosmantuzumab.html

Purity

99.29

Solubility

10 mM in DMSO

Smiles

[Rosmantuzumab]

Molecular Weight

(145.5 kDa)

References & Citations

[1]Zhang M, et al. Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs. PLoS One. 2020 Mar 11;15 (3) :e0229445.